Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Transplantation and Cellular Therapy
|
September 29, 2022
Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis
Anthony C Wood, Ariel Perez Perez, Brian Arciola, et al.
Blood
|
July 24, 2024
JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results
Joseph Pidala, Shernan G Holtan, Kelly Walton, et al.
Blood
|
August 19, 2011
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Renier J Brentjens, Isabelle Rivière, Jae H Park, et al.
Haematologica
|
April 25, 2020
Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma
Jennifer M Logue, Elisa Zucchetti, Christina A Bachmeier, et al.
Blood Cancer Discovery
|
February 2, 2026
Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models
Mackenzie M Lieberman, Jason H Tong, Nkechi U Odukwe, et al.
Cell
|
November 6, 2018
Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism
Marc O Johnson, Melissa M Wolf, Matthew Z Madden, et al.
Blood Advances
|
October 14, 2021
A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease
Aleksandr Lazaryan, Stephanie Lee, Mukta Arora, et al.
Journal for Immunotherapy of Cancer
|
July 29, 2025
Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing
Xiaoqing Yu, Michael D Jain, Meghan A Menges, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B cell Lymphoma
Khushali Jhaveri, Ram Thapa, Dalia Ercan, et al.
Blood Advances
|
April 8, 2025
Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel
Satabdi Saha, Lubna Rehman, Abdur Rehman, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Transplantation and Cellular Therapy
|
September 29, 2022
Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis
Anthony C Wood, Ariel Perez Perez, Brian Arciola, et al.
Blood
|
July 24, 2024
JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results
Joseph Pidala, Shernan G Holtan, Kelly Walton, et al.
Blood
|
August 19, 2011
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Renier J Brentjens, Isabelle Rivière, Jae H Park, et al.
Haematologica
|
April 25, 2020
Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma
Jennifer M Logue, Elisa Zucchetti, Christina A Bachmeier, et al.
Blood Cancer Discovery
|
February 2, 2026
Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models
Mackenzie M Lieberman, Jason H Tong, Nkechi U Odukwe, et al.
Cell
|
November 6, 2018
Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism
Marc O Johnson, Melissa M Wolf, Matthew Z Madden, et al.
Blood Advances
|
October 14, 2021
A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease
Aleksandr Lazaryan, Stephanie Lee, Mukta Arora, et al.
Journal for Immunotherapy of Cancer
|
July 29, 2025
Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing
Xiaoqing Yu, Michael D Jain, Meghan A Menges, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B cell Lymphoma
Khushali Jhaveri, Ram Thapa, Dalia Ercan, et al.
Blood Advances
|
April 8, 2025
Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel
Satabdi Saha, Lubna Rehman, Abdur Rehman, et al.
Page
of 10